GSK.L - GSK plc
NEXT EARNINGS:
Apr 29, 2026
EPS Est: $0.44
|
Rev Est: $7.6B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
Market Cap:
88.79B
Volume:
6,378,113
Avg Volume:
9,228,363
52 Week Range:
1242.5-2282
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Beta:
0.27
Last Dividend:
$72.00
Exchange:
LSE
Country:
GB
Employees:
68,629
IPO Date:
1988-07-01
EPS (TTM):
1.41
P/E Ratio:
12.93
Revenue (TTM):
32.67B
Total Assets:
61.12B
Total Debt:
17.72B
Cash & Equiv:
3.40B
Rev Growth (5Y):
-0.9%
EPS Growth (5Y):
-0.5%
FCF Growth (5Y):
-0.8%
ROCE:
20.4%
Debt/Equity:
1.08
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-04 | $0.25 | $0.24 | +7.1% | $8.6B | $8.4B | +2.9% |
| 2025-10-28 | $0.56 | $0.48 | +17.2% | $8.5B | $8.4B | +1.5% |
| 2025-07-29 | $0.48 | $0.45 | +7.3% | $8.0B | $8.0B | -0.6% |
| 2025-04-29 | $0.44 | $0.39 | +12.3% | $7.5B | $7.2B | +4.6% |
| 2025-02-05 | $0.23 | $0.20 | +17.0% | $8.1B | $7.9B | +3.4% |
| 2024-10-30 | $49.70 | $43.51 | +14.2% | $8.0B | $8.3B | -3.0% |
| 2024-07-31 | $43.40 | $37.87 | +14.6% | $7.9B | $7.4B | +6.7% |
| 2024-05-01 | $43.10 | $36.42 | +18.3% | $7.4B | $7.1B | +3.5% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32.67B | 31.38B | 30.33B | 29.32B | 24.70B | 34.10B | 33.75B | 30.82B | 30.19B | 27.89B | 23.92B | 23.01B |
| Net Income | 5.72B | 2.58B | 4.93B | 14.96B | 4.38B | 5.75B | 4.64B | 3.62B | 1.53B | 912.00M | 8.42B | 2.76B |
| EPS | 1.41 | 0.63 | 1.22 | 3.71 | 1.37 | 1.44 | 1.17 | 0.92 | 0.39 | 0.23 | 2.18 | 0.72 |
| Total Assets | 61.12B | 59.46B | 59.01B | 60.15B | 79.10B | 80.43B | 79.69B | 58.07B | 56.38B | 59.08B | 53.45B | 40.65B |
| Total Debt | 17.72B | 17.15B | 18.02B | 20.99B | 24.17B | 27.15B | 30.51B | 26.06B | 17.09B | 18.79B | 16.63B | 18.78B |
| Cash & Equivalents | 3.40B | 3.87B | 2.94B | 3.72B | 4.27B | 6.29B | 4.71B | 3.87B | 3.83B | 4.90B | 5.83B | 4.34B |
| Operating Cash Flow | 7.30B | 6.55B | 6.77B | 7.40B | 7.95B | 8.44B | 8.02B | 8.42B | 6.92B | 6.50B | 2.57B | 5.18B |
| Free Cash Flow | 5.96B | 3.57B | 4.42B | 5.14B | 5.02B | 6.20B | 5.86B | 6.62B | 4.72B | 4.14B | 668.00M | 3.42B |
| FCF per Share | 1.47 | 0.88 | 1.09 | 1.28 | 1.57 | 1.56 | 1.48 | 1.69 | 1.21 | 1.07 | 0.17 | 0.89 |
| Book Value | 16.38B | 13.67B | 13.35B | 10.60B | 15.05B | 14.59B | 11.98B | 4.36B | (68.00M) | 1.12B | 5.11B | 4.26B |
| Cash & ST Investments | 3.41B | 3.89B | 5.69B | 7.88B | 4.33B | 6.37B | 4.79B | 3.96B | 3.91B | 4.99B | 5.91B | 4.41B |
| ROC Equity | 0.35 | 0.19 | 0.37 | 1.41 | 0.29 | 0.39 | 0.39 | 0.83 | N/A | 0.81 | 1.65 | 0.65 |